Abraham Heifets, Atomwise CEO (Atomwise via website)

Ex­clu­sive: 'Faster is­n't bet­ter' — Atom­wise moves from part­ner­ships to pipeline with TYK2 drug

Atom­wise, one of the first star­tups to start pitch­ing an AI rev­o­lu­tion in drug dis­cov­ery just over a decade ago is now tak­ing a page …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.